United Therapeutics (UTHR) Long-Term Investments (2009 - 2026)
United Therapeutics (UTHR) reported Long-Term Investments of $1.14 billion for Q2 2026, down 40.5% from $1.92 billion a year earlier and down 13.4% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Long-Term Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, United Therapeutics posted Long-Term Investments of $1.78 billion, up 20.4% from FY2024.
- Long-Term Investments has a five-year compound annual growth rate of 9.1% (FY2020 to FY2025).
- By year, Long-Term Investments came in at $1.48 billion in FY2024 (-22.8%), $1.91 billion in FY2023 (+45.1%), $1.32 billion in FY2022 (-20.2%) and $1.65 billion in FY2021 (+43.5%).
- The Q2 2026 figure ranks as the lowest quarterly Long-Term Investments since Q2 2020.
- Year over year, Long-Term Investments gained in four of the last eight quarters, with an average decline of 2.8%.
- The high point for year-over-year Long-Term Investments in five years was Q4 2023 (growth of 45.1%); the low point was Q2 2026 (a decline of 40.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.32 billion (Q1 2026), $1.78 billion (Q4 2025) and $1.57 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | United Therapeutics | 23.13 Bn | 12.62 Bn | 683.80 Mn | 1.14 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Bn |
| Mar 31, 2026 | 1.32 Bn |
| Dec 31, 2025 | 1.78 Bn |
| Sep 30, 2025 | 1.57 Bn |
| Jun 30, 2025 | 1.92 Bn |
| Mar 31, 2025 | 1.71 Bn |
| Dec 31, 2024 | 1.48 Bn |
| Sep 30, 2024 | 1.28 Bn |
| Jun 30, 2024 | 1.33 Bn |
| Mar 31, 2024 | 1.49 Bn |
| Dec 31, 2023 | 1.91 Bn |
| Sep 30, 2023 | 2.06 Bn |
| Jun 30, 2023 | 2.02 Bn |
| Mar 31, 2023 | 1.77 Bn |
| Dec 31, 2022 | 1.32 Bn |
| Sep 30, 2022 | 1.44 Bn |
| Jun 30, 2022 | 1.64 Bn |
| Mar 31, 2022 | 1.56 Bn |
| Dec 31, 2021 | 1.65 Bn |
| Sep 30, 2021 | 1.51 Bn |
API Access
United Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();